US Patent 9789100 Compounds as rearranged during transfection (RET) inhibitors
Patent 9789100 was granted and assigned to GlaxoSmithKline on October, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 2, 2016
Date of Patent
October 17, 2017
Patent Applicant
Patent Application Number
15171229
Patent Inventor Names
Hilary Schenck Eidam
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9789100 Compounds as rearranged during transfection (RET) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
